Stay updated on Taletrectinib ROS1+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Taletrectinib ROS1+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Taletrectinib ROS1+ NSCLC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added a footer note 'Revision: v3.3.3'. Removed the 'HHS Vulnerability Disclosure' link and the 'Revision: v3.3.2' note from the footer.
    Difference
    0.2%
    Check dated 2025-12-23T20:44:11.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The history now shows an added Revision: v3.3.2 and a removed Revision: v3.2.0, reflecting minor metadata updates to the record history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:29:02.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Removal of a government funding/operating-status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-11-18T06:49:38.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    A new version entry has been added to the record history, reflecting an updated Study Status and related fields (e.g., Sponsor/Collaborators, Oversight).
    Difference
    0.1%
    Check dated 2025-11-03T20:36:24.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The page changes remove the old recruitment status and date (Recruiting, 2024-11-21) and replace them with an updated recruitment status (Active, not recruiting) and updated date stamps (2025-10-16 and 2025-10-14) along with expanded section headers. Interpreting this, the study is currently active but not recruiting participants, and there are new or reorganized sections for study headers and contacts.
    Difference
    4%
    Check dated 2025-10-20T12:57:25.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    Added a prominent operating-status notice and a v3.2.0 version tag, replacing the prior v3.1.0.
    Difference
    12%
    Check dated 2025-10-06T04:35:34.000Z thumbnail image

Stay in the know with updates to Taletrectinib ROS1+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Taletrectinib ROS1+ NSCLC Clinical Trial page.